SCHEMBL2865868

SCHEMBL2865868

C=CCn1cnc(N)c1C(=O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAOA P21397 1/20 0.40
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
OPRD1 P41143 1/20 0.37
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28567653 0.84 LMNA (0.45) RAB9AKMT2ALMNACYP1A2CYP3A4
SCHEMBL2860627 0.83 KMT2A (0.39) RAB9APOLBKMT2ALMNAALDH1A1
Hydrochloric Acid SCHEMBL2860622 0.82 KMT2A (0.38) RAB9APOLBKMT2ALMNAALDH1A1
SCHEMBL4355684 0.76 LMNA (0.46) RAB9APOLBKMT2ALMNACYP1A2
SCHEMBL1753091 0.76 SMN1; SMN2 (0.53) RAB9APOLBKMT2ALMNAALDH1A1
SCHEMBL16028248 0.75 SMN1; SMN2 (0.54) RAB9ALMNAALDH1A1KDM4EHPGD
SCHEMBL5185287 0.74 KMT2A (0.40) RAB9APOLBKMT2ALMNACYP1A2
SCHEMBL5186356 0.74 KMT2A (0.40) RAB9APOLBKMT2ALMNACYP1A2
SCHEMBL5187152 0.73 MAPT (0.41) RAB9APOLBKMT2ALMNAALDH1A1
SCHEMBL2866565 0.73 ADORA3 (0.40) RAB9AKMT2ALMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807690-B2 2,3-dihydro-iminoisoindole derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-10-05 US disclosed
US-20100184981-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES CLARK RICHARD 2010-07-22 US disclosed
EP-2202231-A1 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2010-06-30 EP disclosed
US-20090270433-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184981-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES SERPINC1, F7, F2 RAB9A 187/4885POLB 4518/4885KMT2A 2935/4885
US-20090270433-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES SERPINC1, F7, F2 RAB9A 165/4885POLB 4527/4885KMT2A 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.